Literature DB >> 8175732

A beta-adrenergic receptor kinase dominant negative mutant attenuates desensitization of the beta 2-adrenergic receptor.

G Kong1, R Penn, J L Benovic.   

Abstract

The beta-adrenergic receptor kinase (beta ARK) specifically phosphorylates the activated form of the beta 2-adrenergic receptor (beta 2AR) and related G protein-coupled receptors. To further elucidate the role of beta ARK in receptor desensitization, we generated a beta ARK dominant negative mutant by converting an invariant lysine residue in the protein kinase catalytic domain to an arginine. Expressed and purified beta ARK-K220R was able to inhibit wild type beta ARK phosphorylation of the beta 2AR in vitro. When stably transfected into human bronchial epithelial BEAS-2B cells, beta ARK-K220R promoted a > 2-fold increase in beta-agonist-stimulated cAMP production without affecting beta 2AR sequestration. In contrast, beta ARK-K220R had no effect on the desensitization of the prostaglandin E2 receptor response in BEAS-2B cells. These findings directly demonstrate a role for beta ARK in desensitization of the beta 2AR in intact cells and establish the potential utility of using dominant negative mutants to elucidate the substrate specificity of G protein-coupled receptor kinases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8175732

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

Review 1.  G-protein coupled receptor kinases as modulators of G-protein signalling.

Authors:  M Bünemann; M M Hosey
Journal:  J Physiol       Date:  1999-05-15       Impact factor: 5.182

2.  Characterization of the GRK2 binding site of Galphaq.

Authors:  Peter W Day; John J G Tesmer; Rachel Sterne-Marr; Leslie C Freeman; Jeffrey L Benovic; Philip B Wedegaertner
Journal:  J Biol Chem       Date:  2004-10-07       Impact factor: 5.157

3.  Molecular mechanism for inhibition of g protein-coupled receptor kinase 2 by a selective RNA aptamer.

Authors:  Valerie M Tesmer; Sabine Lennarz; Günter Mayer; John J G Tesmer
Journal:  Structure       Date:  2012-06-21       Impact factor: 5.006

4.  Phosphorylation-independent inhibition of parathyroid hormone receptor signaling by G protein-coupled receptor kinases.

Authors:  F Dicker; U Quitterer; R Winstel; K Honold; M J Lohse
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

5.  G protein-coupled receptor kinases: Past, present and future.

Authors:  Konstantin E Komolov; Jeffrey L Benovic
Journal:  Cell Signal       Date:  2017-07-12       Impact factor: 4.315

Review 6.  Regulation of heterotrimeric G protein signaling in airway smooth muscle.

Authors:  Raymond B Penn; Jeffrey L Benovic
Journal:  Proc Am Thorac Soc       Date:  2008-01-01

Review 7.  Embracing emerging paradigms of G protein-coupled receptor agonism and signaling to address airway smooth muscle pathobiology in asthma.

Authors:  Raymond B Penn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-02-16       Impact factor: 3.000

8.  Endogenous Gs-coupled receptors in smooth muscle exhibit differential susceptibility to GRK2/3-mediated desensitization.

Authors:  Kok Choi Kong; Uma Gandhi; T J Martin; Candace B Anz; Huandong Yan; Anna M Misior; Rodolfo M Pascual; Deepak A Deshpande; Raymond B Penn
Journal:  Biochemistry       Date:  2008-08-09       Impact factor: 3.162

9.  Exploiting functional domains of GRK2/3 to alter the competitive balance of pro- and anticontractile signaling in airway smooth muscle.

Authors:  Deepak A Deshpande; Huandong Yan; Kok-Choi Kong; Brian C Tiegs; Sarah J Morgan; Tonio Pera; Reynold A Panettieri; Andrea D Eckhart; Raymond B Penn
Journal:  FASEB J       Date:  2013-10-16       Impact factor: 5.191

10.  GRK2 Constitutively Governs Peripheral Delta Opioid Receptor Activity.

Authors:  Allison Doyle Brackley; Ruben Gomez; Armen N Akopian; Michael A Henry; Nathaniel A Jeske
Journal:  Cell Rep       Date:  2016-08-25       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.